Whole-Transcriptome Sequencing Combined with High-Dimensional Proteomic Technologies Reveals the Potential Value of miR-135b-5p as a Biomarker for Hepatocellular Carcinoma
Table 1
Comparison of clinical pathological parameters between patients in the AFP-high and AFP-low groups.